KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Loans - Loss Allowance (2019 - 2026)

Omega Healthcare Investors' Loans - Loss Allowance history spans 8 years, with the latest figure at $39.2 million for Q1 2026.

  • On a quarterly basis, Loans - Loss Allowance rose 86.37% to $39.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $39.2 million, a 86.37% increase, with the full-year FY2025 number at $35.2 million, up 56.04% from a year prior.
  • Loans - Loss Allowance hit $39.2 million in Q1 2026 for Omega Healthcare Investors, up from $35.2 million in the prior quarter.
  • Over the last five years, Loans - Loss Allowance for OHI hit a ceiling of $209.5 million in Q1 2023 and a floor of $560000.0 in Q1 2024.
  • Historically, Loans - Loss Allowance has averaged $56.1 million across 5 years, with a median of $35.2 million in 2025.
  • Biggest five-year swings in Loans - Loss Allowance: skyrocketed 142157.14% in 2022 and later tumbled 99.73% in 2024.
  • Tracing OHI's Loans - Loss Allowance over 5 years: stood at $18.6 million in 2022, then crashed by 96.13% to $720000.0 in 2023, then skyrocketed by 3028.89% to $22.5 million in 2024, then surged by 56.04% to $35.2 million in 2025, then rose by 11.47% to $39.2 million in 2026.
  • Business Quant data shows Loans - Loss Allowance for OHI at $39.2 million in Q1 2026, $35.2 million in Q4 2025, and $57.6 million in Q3 2025.